An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer.
- Published in:
- Therapeutic Advances in Urology, 2011, v. 3, n. 3, p. 127, doi. 10.1177/1756287211414457
- By:
- Publication type:
- Article
Works matching IS 17562872 AND DT 2011 AND VI 3 AND IP 3
Results: 6
1
2
Diagnosis and management of premalignant penile lesions.
- Published in:
- Therapeutic Advances in Urology, 2011, v. 3, n. 3, p. 151, doi. 10.1177/1756287211412657
- By:
- Publication type:
- Article
3
Laparoendoscopic single-site pyeloplasty.
- Published in:
- Therapeutic Advances in Urology, 2011, v. 3, n. 3, p. 141, doi. 10.1177/1756287211411357
- By:
- Publication type:
- Article
4
Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.
- Published in:
- Therapeutic Advances in Urology, 2011, v. 3, n. 3, p. 107, doi. 10.1177/1756287211407543
- By:
- Publication type:
- Article
5
Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparities.
- Published in:
- Therapeutic Advances in Urology, 2011, v. 3, n. 3, p. 99, doi. 10.1177/1756287211405706
- By:
- Publication type:
- Article
6
Instrumentation in endourology.
- Published in:
- Therapeutic Advances in Urology, 2011, v. 3, n. 3, p. 119, doi. 10.1177/1756287211403190
- By:
- Publication type:
- Article